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The impact of health research: From ‘Know-Do’ to ‘Do-Knowing It’s Been 
Done’ 
Health Research Policy and Systems (HARPS) is publishing a supplement of papers that is 
well timed as it includes accounts of various strategies used by research organisations to 
strengthen the research to policy and practice interface [1]. It comes as the World Health 
Organization (WHO) plans for the 2012 edition of its flagship publication, the World Health 
Report, which will focus on the role of research in improving the health status of populations 
[2].  
The forthcoming World Health Report, to be entitled: ‘No Health Without Research’, reflects 
an ever-growing focus on the vital role of health research, and how best to bridge the ‘Know-
Do’ gap. In 1990 the independent Commission on Health Research for Development 
published a landmark report, Health Research: Essential Link to Equity in Development [3]. 
The WHO has been playing an increasingly important part in promoting the role of health 
research. It organised the Mexico ministerial summit on health research [4] and the 
accompanying World Report on Knowledge for Better Health: Strengthening Health Systems 
[5]. That was followed by the second ministerial summit at Bamako [6] and the First Global 
Symposium on Health Systems Research organised by the WHO/Alliance for Health Policy 
and Systems Research at Montreux in November 2010.  
The specific role of health research in informing health policies has always been a major part 
of the analysis about the importance of health research [7]. In 2003 HARPS published a 
review and analysis of the topic [8] that had been undertaken as part of the lead-up to the 
Mexico summit. That paper made an early claim that, ‘A full review of the many possible 
meanings of research impact reveals that there may be more utilisation in policymaking than 
is sometimes recognised.’[8]  
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The various overlapping themes in the literature include:  
1. promoting the greater use of research and identifying the facilitators of and barriers to 
research making an impact on policy, which is sometimes framed as part of the 
debate about how best to bridge the ‘Know-Do’ gap;  
2. describing specific attempts to enhance the impact made by research on policy;  
3. one-off explorations of how far research has informed health policies in specific 
cases; and 
4. developing systematic methods to assess and monitor the impact made by health 
research on policies, which could seen as addressing what we are calling the ‘Do-
Knowing It’s Been Done’ gap.  
Various studies address these themes, often in overlapping ways. Whilst interest and 
activities have been intensifying in the last decade, it is important to recognise there have 
been major long-standing attempts within some health research systems to develop 
approaches in which policymakers and researchers work together to identify priorities for 
research that will meet the needs of policymakers. A large-scale formative evaluation by 
Maurice Kogan and Mary Henkel of one attempt in the English health department’s R&D 
system was published as early as 1983 [9]. It highlighted many of the difficulties in getting 
policymakers and researchers to develop the productive long-term relationships to improve 
the impact. It also, however, developed many of the concepts that are now used more 
widely, such as the importance of the collaborative approach, the role of knowledge brokers 
and the role of receptor bodies.  A second edition [10] highlighted the continuing attempts to 
address the issue in the English health research system, and a subsequent paper in HARPS 
provided a full account of how 30 years of reform has resulted in a health research system 
that has had successes in meeting the needs of various stakeholders, including some 
policymakers [11].   
 
The recent contribution made by HARPS to the evolving analysis and debates 
In HARPS we have attempted to contribute to all of the four themes outlined above by 
publishing a range of relevant papers, series and supplements. In 2009 we published a 
supplement called SUPPORT Tools for evidence-informed health Policymaking (STP) which 
consisted of a series of guides on how to increase the impact of research on policy with an 
introduction by John Lavis, Andy Oxman and colleagues [12]. This is a major attempt to 
reduce the ‘Know-Do’ gap and, despite the various examples of research making an impact, 
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there is clearly much work still to do to reduce that gap. In turn, that series helped inform an 
innovative approach from Melissa Pearson and colleagues whose article in HARPS 
combines policy sciences traditions with the focus on pathways provided by the SUPPORT 
tools to promote evidence informed policymaking. These combine to facilitate prospective 
policy analysis that informed policymaking on intentional self poisoning in Sri Lanka [13]. 
In May 2010 a symposium was held at Harvard University, Boston, USA, to mark the 20th 
anniversary of the report from the Commission on Health Research for Development. Julio 
Frenk and Lincoln Chen wrote a Commentary on the symposium that was published in 
HARPS.  Frenk and Chen observe that the participants ‘underscored the imperative that 
knowledge be translated into evidence that can guide policy and implementation.’ [14]. At a 
more specific level a paper in HARPS by Rajeev Gupta and colleagues [15] highlights the 
body of evidence that should be translated into policy for cardiovascular disease control in 
India. 
The interest in many countries in the field of increasing research use is illustrated by a range 
of papers published in HARPS in the last 16 months. One paper considers the role being 
played by the print media in 44 countries in Africa, the Americas, Asia, and the Eastern 
Mediterranean as one dimension of the climate for evidence-informed health systems [16]. 
Two linked papers describe surveys used to gather opinions about bridging the gaps 
between research, policy and practice in 10 low and middle income countries [17,18]. 
Various initiatives in this field from The Netherlands have also been reported, including an 
exploration of barriers between epidemiological research and local health policy formation 
[19] and an approach for assessing the use (including impact on policy) of research 
produced by one of the Dutch university medical centres [20]. A further paper describes a 
framework for developing an evidence-based comprehensive tobacco control program in 
Israel [21]. 
A key paper in HARPS by Godfrey Woelk and colleagues from December 2009 won that 
year’s prize in the Medicine category for the best groundbreaking research published in any 
of BioMed Central’s journals: Translating research into policy: lessons learned from 
eclampsia treatment and malaria control in three southern African countries [22]. This 
success is another indication of the increasing importance of the topic, and the paper 
provides further important examples of the use of research in health policy and an insightful 
analysis of barriers and facilitators.  
As noted, there have been various other one-off, and/or small scale, studies on the impact of 
research on policy; some indicating a high level of influence. These include studies of health 
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technology assessments in Quebec, Canada [23] and analysis of 44 operations research 
projects aiming to improve reproductive health services in Guatemala [24]. 
It’s time to recognise the increasingly important role played by health research 
Building on our own paper in 2003 [8], as editors of HARPS we have been pushing the case 
for increasing recognition that health research does impact on policy more frequently than is 
often acknowledged [25]. Of course not all heath research can make an impact on policy, 
nor should this be expected.  However, whilst it is important that a major focus is maintained 
on bridging the ‘Know-Do’ gap, it is also time that more attention was paid to the ‘Do-
Knowing It’s Been Done’ gap so as to ensure that evidence is captured about when and how 
health research makes an impact on policy. 
Developing robust techniques to assess the impact of health research has been recognised 
in the 1990s as being important for various reasons: it provides accountability for funds 
spent, justification for future spending and also helps identify ways to organise health 
research so as to achieve greater impacts in the future [26]. If real progress is to be made in 
evaluating the different mechanisms used to increase the use of research, it could be argued 
that it is important to know what impact has been made by the research that is translated 
into action. As a corollary to the collaborative approach developed by Kogan and Henkel [9], 
there is recognition of the need to focus on issues at the interfaces between policymakers 
and researchers as a way of helping to understand how the impact on policy has come 
about [26,27]. The Payback Framework developed in the mid 1990s by Buxton and Hanney 
[26], and elaborated in an article in HARPS [27], addresses these concerns. It incorporates 
consideration of the permeability of the interfaces between the research system and the 
wider political and healthcare systems. The issue of permeability at the interfaces includes 
questions about how far the wider healthcare, political and social systems can collaborate 
with researchers to produce an agenda that will engage researchers, and how far the 
findings from research can make an impact on the wider systems. The Payback Framework 
consists not only a multi-dimensional categorisation of benefits from research, but also a 
model of the processes of research production and use that can help in assessing the 
benefits achieved [26]. In this approach, therefore, the analysis of the value of the interface 
mechanisms used to help achieve impacts is informed by the assessment of the actual 
impacts that arise from the translation of the research.  
Such considerations could be important in progressing effective implementation of the 
framework developed by Lavis and colleagues [28] for evaluating what has been done to 
promote efforts to link research to action. Their framework covers a wide range of 
mechanisms that might be used, including: push efforts by producers of research; user pull 
5 
 
efforts; exchange efforts involving researchers and users working together in ways such as 
through the use of knowledge brokers; and integrated efforts. Their framework also 
recognises the importance of evaluating such mechanisms. Approaches such as the 
Payback Framework [26] provide a way to assess the wider impacts of the research that is 
translated through the various possible translation mechanisms available. Therefore, these 
ways of assessing the wider impacts might assist attempts to evaluate the effectiveness of 
the various translation mechanisms.  
Whereas some attempts to assess the impact of research look just at policy, other 
frameworks, such as the Payback Framework, include impact on policy as part of a multi-
dimensional categorisation of benefits that also includes health and health equity benefits as 
well as broader economic benefits [26]. Indeed, establishing the impact on policy (especially 
using a broad definition to include clinical policies) can be seen as a key factor in helping to 
identify the wider impacts [29].  
To demonstrate when and how research has an impact on policy, studies can either start 
with research and trace the impact forwards, or start with policies and attempt to trace the 
impact backwards to the relevant research that might have influenced the policy. In our 2003 
review we suggested that the evidence indicated it could be less difficult to trace the impact 
forwards than it was to work backwards, and this opinion was strengthened by a review in 
2007 [29]. Whilst it might be more difficult to trace policy impacts back to specific pieces of 
research, there is increasing evidence of policymakers acknowledging research can inform 
their decision-making. In a recent study of national policymakers in six countries Adnan 
Hyder and colleagues show that whilst there are various barriers to the use of research, the 
policymakers interviewed, ‘were unequivocal in their support for health research and the high 
value they attribute to it’[30].  
Several issues will have to be addressed in any attempts to put greater emphasis on 
bridging the ‘Do-Knowing It’s Been Done’ gap. There are the different, although related, 
processes of using specific research results through commissioning or pushing primary 
research, and using secondary research through reviews and synthesis. Indeed, there is 
sometimes a lack of clarity in the literature about whether the emphasis is on enhancing (and 
assessing) the use of the findings produced by researchers within the local 
healthcare/research system, or on enhancing (and assessing) the use of the relevant parts 
of the global body of health research. Clearly both activities are important, and there is an 
increasingly diverse range of approaches used for pulling together locally generated and 
synthesised global knowledge in a way that is most appropriate for policymakers in specific 
countries. Furthermore, there are overlaps in that a collaborative approach might be as 
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valuable in getting policymakers to pay attention to secondary research as it is with primary 
research. However, if the case is to made for funding local primary research in low and 
middle income countries (because, for example, its findings are more likely to be relevant to 
policymakers in those countries), then it is important that sufficient attention is given to 
assessing the impact of such research on policy.  
Extending the analysis: a new supplement in HARPS 
HARPS is now publishing a supplement consisting of a diverse range of papers first 
presented at a conference on getting research into policy and practice in the field of sexual 
and reproductive health (SRH) and HIV/AIDS. These papers cover a wide range of topics, 
many of which are related to the main themes identified above, including the importance of 
focussing on ways not only of enhancing the impact of research (on policy and practice) but 
also of demonstrating that impact has been achieved. In an introductory paper Sally 
Theobald and colleagues state:  
The contributors to this supplement provide a body of critical analysis of 
communications and engagement strategies across the spectrum of SRH and 
HIV/AIDS research through the testing of different models for the research-to-
policy interface. They provide new insights on how researchers and 
communication specialists can respond to changing policy climates to create 
windows of opportunity for influence.[1]. 
Here we present a flavour of the wide range of approaches and topics described by 
giving a brief outline of key points from three contrasting papers. Eleanor Hutchinson 
and colleagues examine national policymaking for cotrimoxazole as a preventive 
therapy for HIV infected individuals in Malawi, Uganda and Zambia [31]. The approach 
adopted by the authors was informed by a recent overview of the health policy 
literature in low and middle income countries. That review concluded with a call for 
analyses which consist of comparative, multi-country studies using rigorous case 
studies which deliberately seek to explain health policy changes in these settings [32]. 
Hutchinson and colleagues identify several factors that influenced the variable impact 
of the research in the different countries, and observe that while the findings from 
randomised controlled trials were not necessarily translated into policy so swiftly, ‘local 
operational research results seem to have been taken up more quickly’[31]. 
Rose Oronje and colleagues [33] use a case study approach to describe the 
experiences of the African Population and Health Research Center in Nairobi, Kenya, 
and its partners, in cultivating the interest and building the capacity of the media in 
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evidence-based reporting of reproductive health issues in sub-Saharan Africa. They 
conclude that the media can play a valuable role in communicating important research 
findings and raising the profile of overlooked and contentious public health issues to 
the public, including political leaders, policymakers and key stakeholders [33].  
Alan Whiteside and Fiona Henry [34] examine how, where and why there was a 
considerable impact made by the 2007 report on the HIV and AIDS epidemic in 
Swaziland entitled Reviewing ‘Emergencies’ for Swaziland: Shifting the Paradigm in a 
New Era [35]. Adopting the approach of tracing the impact forwards from the original 
research, as described above, they explore how following a targeted communications 
effort, that report succeeded in raising the profile of the epidemic as a humanitarian 
emergency requiring urgent action from international organisations, donors, and 
governments. In the literature on assessing the impacts made by research on health 
policies it has been stressed that the quality of the research can be seen as an 
important factor in achieving impacts [8,26], and this is well-illustrated in Whitehead 
and Henry’s conclusion that ‘The credibility of both evidence and researcher play an 
important role in the use of research.’[34]. Finally, the authors end with a key 
observation that not only did the original report achieve many of its goals and spur an 
international dialogue around the issues, but also the evaluation of the report’s impact 
provides, ‘additional lessons, which can be applied to help maximise the impact of 
research in the future.’[34]. 
So, the new supplement in HARPS makes significant additions to the growing body of  
literature, from HARPS and elsewhere, that research can inform health policies, that 
there are various barriers and facilitators that should be analysed, and that it is also 
important to expand the analysis and bridge the ‘Do-Knowing It’s Been Done’ gap.  
  
Competing interests 
SH and MG-B receive funding from a range of organisations with an interest in health 
research, including some specifically mentioned in this editorial such as the World Health 
Organization and the Alliance for Health Policy and Systems Research. 
 
Acknowledgements 
We are very grateful to Dr Tracey Koehlmoos for helpfully commenting on a draft version of 
this editorial, but responsibility for the views expressed lies solely with the authors. 
 
8 
 
 
References 
1. Theobald S, Tulloch O, Crichton J, Hawkins K, Zulu E, Mayaud P, Parkhurst J, Whiteside 
A, Standing H: Strengthening the research to policy and practice interface: 
exploring strategies used by research organisisations working on sexual and 
reproductive health and HIV/AIDS Health Res Policy Syst  2011, 9(Suppl 1):S2. 
2. Pang T, Terry RF, The PloS Medicine Editors: WHO/PloS Collection “No Health 
Without Research”: A Call for Papers. PloS Medicine 2011, 8:1. 
3. Commission on Health Research for Development: Health Research: Essential Link to 
Equity in Development. New York: Oxford University Press; 1990.  
4. World Health Organization: The Mexico statement on health research. 2004 
[http://www.who.int/rpc/summit/agenda/Mexico_Statement-English.pdf]. World Health 
Organization.  
5. World Health Organization: World report on knowledge for better health. 2004 
[http://www.who.int/rpc/wr2004]. World Health Organisation. 
6. World Health Organization: The Bamako call to action on research for health. 2008 
[http://www.who.int/gb/ebwha/pdf_files/EB124/B124_12Add2-en.pdf]. World Health 
Organization. 
7. Lavis JN, Posada FB, Haines A, Osei E: Use of research to inform public 
policymaking. Lancet 2004, 364:1615-21.  
8. Hanney SR, Gonzalez-Block MA, Buxton MJ, Kogan M: The utilisation of health 
research in policy-making: concepts, examples and methods of assessment. 
Health Res Policy Syst 2003, 1:2.  
9. Kogan M, Henkel M: Government and Research: The Rothschild Experiment in a 
Government Department London: Heinemann; 1983.  
10. Kogan M, Henkel M, Hanney S: Government and Research: Thirty Years of Evolution. 
2nd edition. Dordrecht: Springer; 2006.  
11. Hanney S, Kuruvilla S, Soper B, Mays N: Who needs what from a national health 
research system: Lessons from reforms to the English health department’s R&D 
system. Health Res Policy Syst 2010, 8:11.  
12. Lavis JN, Oxman AD, Lewin S, Fretheim A: SUPPORT Tools for evidence-informed 
health Policymaking (STP). Health Res Policy Syst 2009, 7(Suppl 1):I1.  
13. Pearson M, Zwi AB, Buckley NA: Prospective policy analysis: how an epistemic 
community informed policymaking on intentional self poisoning in Sri Lanka. 
Health Res Policy Syst 2010, 8:19.  
14. Frenk H, Chen L: Overcoming gaps to advance global health equity: a symposium 
on new directions for research. Health Res Policy Syst 2011, 9:11.  
15. Gupta R, Guptha S, Joshi R, Xavier D: Translating evidence into policy for 
cardiovascular disease control in India. Health Res Policy Syst 2011, 9:8. 
16. Cheung A, Lavis JN, Hamandi A, El-Jardali F, Sachs J, Sewankambo N, Knowledge-
Translation Platform Evaluation Team: Climate for evidence-informed health 
systems: A print media analysis in 44 low- and middle-income countries that host 
knowledge-translation platforms. Health Res Policy Syst 2011, 9:7. 
17. Cameron D, Lavis JN, Guindon GE, Akhtar T, Posada FB, Ndossi GD, Boupha B, 
Research to Policy and Practice Study Team: Bridging the gaps among research, 
9 
 
policy and practice in ten low- and middle-income countries: Development and 
testing of a questionnaire for researchers. Health Res Policy Syst 2010, 8:4. 
18. Guindon GE, Lavis JN, Boupha B, Shi G, Sidibe M, Turdaliyeva B, Research to Policy 
and Practice Study Team (RPPST): Bridging the gaps among research, policy and 
practice in ten low- and middle-income countries: Development and testing of a 
questionnaire for health-care providers. Health Res Policy Syst 2010, 8:3. 
19. de Goede J, Putters K, van der Grinten T, van Oers HAM: Knowledge in process? 
Exploring barriers between epidemiological research and local health policy 
development. Health Res Policy Syst 2010, 8:26. 
20. Mostert SP, Ellenbroek SPH, Meijer I, van Ark G, Klasen EC: Societal output and use 
of research performed by health research groups. Health Res Policy Syst 2010, 8:30. 
21. Rosen L, Rosenberg E, McKee M, Gan-Noy S, Levin D, Mayshar E, Shacham G, 
Borowski J, Nun GB, Lev B, the Healthy Israel 2020 Tobacco Control Subcommittee: A 
framework for developing an evidence-based, comprehensive tobacco control 
program. Health Res Policy Syst 2010, 8:17.  
22. Woelk G, Daniels K, Cliff J, Lewin S, Sevene E, Fernandes B, Mariano A, Matinhure S, 
Oxman AD, Lavis JN, Stålsby Lundborg C. Translating research into policy: lessons 
learned from eclampsia treatment and malaria control in three southern African 
countries. Health Res Policy Syst 2009, 7:31.  
23. Jacob R, McGregor M: Assessing the impact of health technology assessment. Int J 
Tech Assess Health Care 1997, 13:68-80.  
24. Brambila C, Ottolenghi E, Marin C, Bertrand CT: Getting results used: evidence from 
reproductive health programmatic research in Guatemala. Health Policy Plan 2007, 
22:234-245. 
25. Hanney S, González-Block MA: Evidence-informed health policy: are we beginning 
to get there at last? Health Res Policy Syst 2009, 7:30. 
26. Buxton MJ, Hanney S: How can payback from health services research be 
assessed?  J Health Serv Res Policy 1996, 1:35-43.  
27. Hanney S, Grant J, Wooding S, Buxton M: Proposed methods for reviewing the 
outcomes of health research: the impact of funding by the UK's Arthritis Research 
Campaign. Health Res Policy Syst 2004, 2:4.  
28. Lavis JN, Lomas J, Hamid M, Sewankambo NK: Assessing country level efforts to 
link research to action. Bull World Health Organ 2006, 84:620-628. 
29. Hanney S, Buxton M, Green C, Coulson DJR: An assessment of the impact of the 
NHS Health Technology Assessment Programme. Health Technol Assess 2007, 
11:53.  
30. Hyder AA, Corluka A, Winch PJ, El-Shinnawy A, Ghassany H, Malekafzali H, Lim MK, 
Mfutso-Bengo J, Segura E, Ghaffar A: National policy-makers speak out: are 
researchers giving them what they need? Health Policy Plan 2011, 26:73-82. 
31. Hutchinson E, Parkhurst J, Phiri S, Gibb DM, Chishinga N, Droti B, Hoskins S: National 
policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: 
the relationship between Content, Evidence and Links. Health Res Policy Syst  2011, 
9(Suppl 1):S6. 
32. Gilson L, Raphaely N: The terrain of health policy analysis in low and middle 
income countries: a review of published literature 1994-2007. Health Policy Plan 
2008, 23:294-307. 
33. Oronje RN, Undie CC, Zulu EM, Crichton J: Engaging media in communicating 
research on sexual and reproductive health and rights in sub-Saharan Africa: 
experiences and lessons learned. Health Res Policy Syst  2011, 9(Suppl 1):S7.   
34. Whiteside A, Henry FE: The impact of HIV and AIDS research: a case study from 
Swaziland. Health Res Policy Syst  2011, 9(Suppl 1):S9. 
10 
 
35. Whiteside A, Whalley A: Reviewing ‘Emergencies’ for Swaziland: Shifting the Paradigm 
in a New Era. Durban: Health Economics and HIV/AIDS Research Division, University of 
Kwazulu-Natal; 2007. 
 
